Accurate Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Accurate Wealth Management's BMY Position: Q2 2026 in Review
Accurate Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, buying an estimated $78.7K and bringing the position to 8,259 shares worth $476K. The position accounts for 0.05% of the portfolio, ranked #364.
Accurate Wealth Management first reported a position in BMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.91M in Q1 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Accurate Wealth Management held 8,259 shares of Bristol-Myers Squibb worth $476K as of Q2 2026.
- Accurate Wealth Management bought 1,371 Bristol-Myers Squibb shares in Q2 2026, an estimated $78.7K.
- Bristol-Myers Squibb made up 0.05% of Accurate Wealth Management's portfolio in Q2 2026, its #364 holding.
- Accurate Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 20 quarters since.
- Accurate Wealth Management's Bristol-Myers Squibb position peaked at $1.91M in Q1 2022.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.